{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:22:57Z","timestamp":1755220977488,"version":"3.43.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507800; 2021YFA1100904"],"award-info":[{"award-number":["2023YFC2507800; 2021YFA1100904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070178; 82270162"],"award-info":[{"award-number":["82070178; 82270162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for hematologic malignancies. However, the initial clinical experience with allo-HSCT revealed a concerning prevalence of severe graft-versus-host disease (GVHD) and graft failure. Subsequent randomized studies highlighted the role of anti-thymocyte globulin (ATG) in reducing acute and chronic GVHD and graft failure, although it did not improve overall survival. Pharmacodynamic studies have established an association between ATG concentration and the incidence of GVHD and life-threatening infections. However, ATG concentration at designated timepoints showed no such correlations with non-relapse mortality and overall survival in allo-HSCT. There is a delicate balance between ATG exposure and the outcomes of allo-HSCT. More specifically, insufficient ATG exposure may diminish its function on GVHD prophylaxis, while excessive ATG may delay immune reconstitution and increase risk of disease relapse and infection. Considering the significant inter-individual heterogeneity in ATG pharmacokinetics, individualized ATG dosing could potentially increase the proportion of transplant recipients attaining the optimal ATG exposure. Recent studies have shown that individualized ATG dosing, guided by absolute lymphocyte count or therapeutic drug monitoring, can improve optimal exposure attainment rate. Which indicated a potential approach to achieve superior transplant outcomes. This review summarizes the advances and the challenges of individualized ATG dosing in allo-HSCT.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1634157","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T04:10:59Z","timestamp":1754626259000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing anti-thymocyte globulin dosing in allogeneic hematopoietic stem cell transplantation: individualized approaches and clinical implications"],"prefix":"10.3389","volume":"16","author":[{"given":"Haitao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jishan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: A global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"Jama"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/s2352-3026(15)00028-9","article-title":"One million haemopoietic stem-cell transplants: A retrospective observational study","volume":"2","author":"Gratwohl","year":"2015","journal-title":"Lancet Haematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/nejm197107152850310","article-title":"The clinical use of antilymphocyte globulin","volume":"285","author":"Najarian","year":"1971","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-01169-7","article-title":"Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges","volume":"56","author":"Xu","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(09)70225-6","article-title":"Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: A randomised, open-label, multicentre phase 3 trial","volume":"10","author":"Finke","year":"2009","journal-title":"Lancet Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-host disease","volume":"374","author":"Kr\u00f6ger","year":"2016","journal-title":"New Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.10.2942","article-title":"Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from gruppo italiano trapianti midollo osseo (Gitmo)","volume":"98","author":"Bacigalupo","year":"2001","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.75.8177","article-title":"Prospective, randomized, double-blind, phase iii clinical trial of anti\u2013T-lymphocyte globulin to assess impact on chronic graft-versus-host disease\u2013free survival in patients undergoing hla-matched unrelated myeloablative hematopoietic cell transplantation","volume":"35","author":"Soiffer","year":"2017","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2165\/11315940-000000000-00000","article-title":"Rabbit antithymocyte globulin (Thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology","volume":"70","author":"Gaber","year":"2010","journal-title":"Drugs"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.07.004","article-title":"Different outcomes between cyclophosphamide plus horse or rabbit antithymocyte globulin for hla-identical sibling bone marrow transplant in severe aplastic anemia","volume":"18","author":"Atta","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-052308","article-title":"Bone marrow transplantation for severe aplastic anemia: A randomized controlled study of conditioning regimens","volume":"109","author":"Champlin","year":"2007","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2217\/imt.15.128","article-title":"Antithymocyte globulin in allogeneic hematopoietic cell transplantation: benefits and limitations","volume":"8","author":"Nishihori","year":"2016","journal-title":"Immunotherapy"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_752_19","article-title":"Anti-thymocyte globulin in haematology: recent developments","volume":"150","author":"Siddiqui","year":"2019","journal-title":"Indian J Med Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.148510","article-title":"Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: A review from the acute leukemia working party of the european society for blood and marrow transplantation","volume":"102","author":"Baron","year":"2017","journal-title":"Haematologica"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12514","article-title":"A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations","volume":"13","author":"Popow","year":"2013","journal-title":"Am J Transplant"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27619","article-title":"Differential clinical and immunological impacts of anti-T-lymphocyte globulin (Atlg) vs. Anti-thymocyte globulin (Atg) in preventing graft-versus-host disease post-allogeneic hematopoietic stem cell transplantation: A comparative study","volume":"100","author":"Notarantonio","year":"2025","journal-title":"Am J Hematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jtct.2022.03.018","article-title":"Optimal active anti-thymocyte globulin exposure associated with minimum risk of virus reactivation and comparable acute graft-versus-host disease under adult myeloablative haploidentical peripheral blood stem cell transplantation","volume":"28","author":"Wang","year":"2022","journal-title":"Transplant Cell Therapy Off Publ Am Soc Transplant Cell Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.02.027","article-title":"High rabbit-antihuman thymocyte globulin levels are associated with low likelihood of graft-vs-host disease and high likelihood of posttransplant lymphoproliferative disorder","volume":"16","author":"Podgorny","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and cd4+ Immune reconstitution in paediatric haemopoietic cell transplantation: A multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200102150-00021","article-title":"Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model","volume":"71","author":"Pr\u00e9ville","year":"2001","journal-title":"Transplantation"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000150210.77543.1b","article-title":"Antithymocyte globulin induces ex vivo and in vivo depletion of myeloid and plasmacytoid dendritic cells","volume":"79","author":"Fang","year":"2005","journal-title":"Transplantation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000251975.81281.22","article-title":"Antithymocyte globulins suppress dendritic cell function by multiple mechanisms","volume":"83","author":"Naujokat","year":"2007","journal-title":"Transplantation"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9599-2","article-title":"Anti-T lymphocyte globulin (Atg) induces generation of regulatory T cells, at least part of them express activated cd44","volume":"32","author":"Shimony","year":"2012","journal-title":"J Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12448","article-title":"Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation","volume":"28","author":"Valdez-Ortiz","year":"2015","journal-title":"Transpl Int"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.11.676","article-title":"Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation","volume":"21","author":"Storek","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/jcm12020730","article-title":"Pre-transplant total lymphocyte count determines anti-thymocyte globulin exposure, modifying graft-versus-host disease incidence and post-transplant thymic restoration: A single-center retrospective study","volume":"12","author":"Grasso","year":"2023","journal-title":"J Clin Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.191","article-title":"Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: A randomized trial","volume":"49","author":"Wang","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0214-6","article-title":"Population pharmacokinetic modeling of thymoglobulin((R)) in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing","volume":"54","author":"Admiraal","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30029-7","article-title":"Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: A multicentre, retrospective, pharmacodynamic cohort analysis","volume":"4","author":"Admiraal","year":"2017","journal-title":"Lancet Haematol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-502385","article-title":"Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome","volume":"123","author":"Lindemans","year":"2014","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012670","article-title":"Effect of rabbit atg pk on outcomes after tcr-\u03b1\u03b2\/cd19-depleted pediatric haploidentical hct for hematologic Malignancy","volume":"8","author":"Dvorak","year":"2024","journal-title":"Blood Adv"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2024.01.004","article-title":"Impact of rabbit anti-thymocyte globulin (Atg) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients","volume":"26","author":"Lakkaraja","year":"2024","journal-title":"Cytotherapy"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-022-03342-8","article-title":"Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation","volume":"116","author":"Teramoto","year":"2022","journal-title":"Int J Hematol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3026(21)00375-6","article-title":"Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (Parachute): A single-arm, phase 2 clinical trial","volume":"9","author":"Admiraal","year":"2022","journal-title":"Lancet Haematol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27068","article-title":"Targeted dosing of anti-thymocyte globulin in adult unmanipulated haploidentical peripheral blood stem cell transplantation: A single-arm, phase 2 trial","volume":"98","author":"Wang","year":"2023","journal-title":"Am J Hematol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802163321","article-title":"Mechanisms of action of antithymocyte globulin: old dogs with new tricks","volume":"49","author":"Mohty","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199403150-00010","article-title":"A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin","volume":"57","author":"Rebellato","year":"1994","journal-title":"Transplantation"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000164159.20075.16","article-title":"Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways","volume":"79","author":"Zand","year":"2005","journal-title":"Transplantation"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/s1567-5769(02)00253-9","article-title":"Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells","volume":"3","author":"Monti","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2006050422","article-title":"A novel mechanism of action for anti-thymocyte globulin: induction of cd4+Cd25+Foxp3+ Regulatory T cells","volume":"17","author":"Lopez","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.7.1073","article-title":"Bone marrow nk1.1(-) and nk1.1(+) T cells reciprocally regulate acute graft versus host disease","volume":"189","author":"Zeng","year":"1999","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/01.Tp.0000053198.99206.E6","article-title":"Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins","volume":"75","author":"Michallet","year":"2003","journal-title":"Transplantation"},{"key":"B46","article-title":"Mechanisms of immunosuppression induced by antithymocyte globulins and okt3","volume":"15","author":"Bonnefoy-Berard","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"B47","article-title":"Rabbit-immunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation","volume":"90","author":"Remberger","year":"2005","journal-title":"Haematologica"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/s1083-8791(03)00127-7","article-title":"Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially hla-matched blood hematopoietic progenitor cell transplantation","volume":"9","author":"Waller","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"B49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jtct.2025.01.893","article-title":"Bodyweight and absolute lymphocyte count-based dosing of rabbit anti-thymocyte globulin results in early cd4(+) immune reconstitution in patients with inborn errors of metabolism undergoing umbilical cord blood transplantation","volume":"31","author":"Drozdov","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.11.027","article-title":"Total and active rabbit antithymocyte globulin (Ratg;Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation","volume":"15","author":"Call","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.05.001","article-title":"Heterogeneous clearance of antithymocyte globulin after cd34+-selected allogeneic hematopoietic progenitor cell transplantation","volume":"11","author":"Kakhniashvili","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1208\/s12248-020-0419-6","article-title":"Quantification of T cell binding polyclonal rabbit anti-thymocyte globulin in human plasma with liquid chromatography tandem-mass spectrometry","volume":"22","author":"Amrani","year":"2020","journal-title":"AAPS J"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.106542","article-title":"In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia","volume":"99","author":"Feng","year":"2014","journal-title":"Haematologica"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0277-6","article-title":"New directions for rabbit antithymocyte globulin (Thymoglobulin(\u00ae)) in solid organ transplants, stem cell transplants and autoimmunity","volume":"74","author":"Mohty","year":"2014","journal-title":"Drugs"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000184575.00717.25","article-title":"Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation","volume":"27","author":"Seidel","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-014-0214-6","article-title":"Population pharmacokinetic modeling of thymoglobulin(\u00ae) in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing","volume":"54","author":"Admiraal","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-092130","article-title":"Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing","volume":"110","author":"Komanduri","year":"2007","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2010.05.004","article-title":"Advances in umbilical cord transplantation: the role of thymoglobulin\/atg in cord blood transplantation","volume":"23","author":"Mohty","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422501","article-title":"Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an hla-identical sibling","volume":"342","author":"Rocha","year":"2000","journal-title":"New Engl J Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2025.05.009","article-title":"Adjustment of low-dose atg exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: A prospective multicenter study","volume":"27","author":"Kuwano","year":"2025","journal-title":"Cytotherapy"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.166","article-title":"Igg antibodies to atg early after pediatric hematopoietic sct increase the risk of acute gvhd","volume":"47","author":"Jol-van der Zijde","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"B62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.trim.2012.06.003","article-title":"Effects of different serum-levels of atg after unrelated donor umbilical cord blood transplantation","volume":"27","author":"Remberger","year":"2012","journal-title":"Transpl Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12620","article-title":"Correlation of rabbit antithymocyte globulin serum levels and clinical outcomes in children who received hematopoietic stem cell transplantation from an alternative donor","volume":"20","author":"Elmahdi","year":"2016","journal-title":"Pediatr Transplant"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.04.007","article-title":"High Serum Level of Antithymocyte Globulin Immediately before Graft Infusion Is Associated with a Low Likelihood of Chronic, but Not Acute, Graft-Versus-Host Disease","volume":"20","author":"Chawla","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27195","article-title":"Individualized rabbit anti-thymocyte globulin dosing in adult haploidentical hematopoietic cell transplantation with high-risk hematologic Malignancy: exposure-response analysis and population pharmacokinetics simulations","volume":"99","author":"Teramoto","year":"2024","journal-title":"Am J Hematol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703306","article-title":"Pre-emptive therapy of acute graft-versus-host disease: A pilot study with antithymocyte globulin (Atg)","volume":"28","author":"Bacigalupo","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.151","article-title":"Pre-emptive treatment of acute gvhd: A randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants","volume":"45","author":"Bacigalupo","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2021.06.003","article-title":"A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin","volume":"23","author":"Khanolkar","year":"2021","journal-title":"Cytotherapy"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/jcm11041106","article-title":"Addition of a single low dose of anti T-lymphocyte globulin to post-transplant cyclophosphamide after allogeneic hematopoietic stem cell transplant: A pilot study","volume":"11","author":"Xue","year":"2022","journal-title":"J Clin Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704758","article-title":"Antilymphocyte\/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects","volume":"35","author":"Bacigalupo","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.04.015","article-title":"Prospective study of a modified post-transplantation cyclophosphamide regimen for severe aplastic anemia patients with hla-haploidentical transplantation","volume":"29","author":"Wu","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-721936","article-title":"Excellent T-cell reconstitution and survival depend on low atg exposure after pediatric cord blood transplantation","volume":"128","author":"Admiraal","year":"2016","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.065","article-title":"Rabbit antithymocyte globulin serum levels: factors impacting the levels and clinical outcomes impacted by the levels","volume":"25","author":"Jamani","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284632","article-title":"Anti-T-lymphocyte globulin exposure is associated with acute graft- versus -host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: A multinational prospective study","volume":"109","author":"Oostenbrink","year":"2024","journal-title":"Haematologica"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018030247","article-title":"Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin","volume":"3","author":"Dabas","year":"2019","journal-title":"Blood Adv"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70151","article-title":"(S263) pharmacokinetic-guided atg dosing optimizes outcomes in myeloablative haplo-cord hct","volume":"9","author":"Yang","year":"2025","journal-title":"HemaSphere"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1177\/20406207211063783","article-title":"Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin","volume":"12","author":"Seo","year":"2021","journal-title":"Ther Adv Hematol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.06.005","article-title":"Preconditioning absolute lymphocyte count and transplantation outcomes in matched related donor allogeneic hematopoietic stem cell transplantation recipients with reduced-intensity conditioning and antithymocyte globulin treatment","volume":"26","author":"Woo","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B79","doi-asserted-by":"publisher","first-page":"15399","DOI":"10.1038\/s41598-020-72415-7","article-title":"Antithymocyte globulin administration in patients with profound lymphopenia receiving a pbsc purine analog\/busulfan-based conditioning regimen allograft","volume":"10","author":"Jullien","year":"2020","journal-title":"Sci Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.02.026","article-title":"Does lymphocyte count impact dosing of anti-thymocyte globulin in unrelated donor stem cell transplantation","volume":"26","author":"Heelan","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0339-2","article-title":"Pharmacokinetics, pharmacodynamics and pharmacogenomics of immunosuppressants in allogeneic haematopoietic cell transplantation: part I","volume":"55","author":"McCune","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0340-9","article-title":"Pharmacokinetics, pharmacodynamics, and pharmacogenomics of immunosuppressants in allogeneic hematopoietic cell transplantation: part ii","volume":"55","author":"McCune","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-158994","article-title":"Individualized dosing of anti-thymocyte globulin led to reduced cmv\/ebv reactivation and superior overall survival in adult unmanipulated haploidentical peripheral blood stem cell transplantation: A prospective phase ii study","volume":"140","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.828094","article-title":"Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept","volume":"13","author":"Meesters-Ensing","year":"2022","journal-title":"Front Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70151","article-title":"(S256) targeted dosing of anti-thymocyte globulin versus fixed dosing strategy in patients undergoing unmanipulated haploidentical haematopoietic stem-cell transplantation: A randomized, multicenter, phase 3 clinical trial","volume":"9","author":"Dou","year":"2025","journal-title":"HemaSphere"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-023-01252-4","article-title":"Population pharmacokinetics of total rabbit anti-thymocyte globulin in non-obese adult patients undergoing hematopoietic cell transplantation for hematologic Malignancy","volume":"62","author":"Takahashi","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016001552","article-title":"Atg in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint","volume":"1","author":"Kekre","year":"2017","journal-title":"Blood Adv"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0643-9","article-title":"Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose","volume":"55","author":"Shichijo","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014836","article-title":"Improved survival with model-based dosing of anti-thymocyte globulin in pediatric hematopoietic cell transplantation","volume":"9","author":"Admiraal","year":"2025","journal-title":"Blood Adv"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3206","article-title":"Better rejection-free survival at three years in kidney transplant recipients with model-informed precision dosing of mycophenolate mofetil","volume":"116","author":"Villeneuve","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1097\/ftd.0000000000001078","article-title":"Artificial intelligence and machine learning approaches to facilitate therapeutic drug management and model-informed precision dosing","volume":"45","author":"Poweleit","year":"2023","journal-title":"Ther Drug Monit"},{"key":"B92","doi-asserted-by":"publisher","first-page":"85","DOI":"10.63278\/1322","article-title":"The role of artificial intelligence in personalized medicine: challenges and opportunities","volume":"31","author":"Pooja","year":"2025","journal-title":"Metallurgical Materials Eng"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1634157\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T04:11:01Z","timestamp":1754626261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1634157\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":92,"alternative-id":["10.3389\/fimmu.2025.1634157"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1634157","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"article-number":"1634157"}}